研究弥漫大 B 细胞淋巴瘤表观遗传学的新型数字液滴 PCR 方法:BMI1、EZH2 和 USP22 基因的作用

IF 2.2 4区 医学 Q3 HEMATOLOGY
Alessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, Valter Gattei, Samantha Pozzi, Valentina Donati, Stefania Bettelli, Elisa Forti, Giovanna Mansueto, Arianna Di Napoli, Maria Christina Cox, Leonardo Flenghi, Pietro Rossi, Guido Volpe, Dimitri Dardanis, Clara Bono, Francesca Guerrini, Riccardo Morganti, Stefano Sacchi, Sara Galimberti
{"title":"研究弥漫大 B 细胞淋巴瘤表观遗传学的新型数字液滴 PCR 方法:BMI1、EZH2 和 USP22 基因的作用","authors":"Alessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, Valter Gattei, Samantha Pozzi, Valentina Donati, Stefania Bettelli, Elisa Forti, Giovanna Mansueto, Arianna Di Napoli, Maria Christina Cox, Leonardo Flenghi, Pietro Rossi, Guido Volpe, Dimitri Dardanis, Clara Bono, Francesca Guerrini, Riccardo Morganti, Stefano Sacchi, Sara Galimberti","doi":"10.1111/ijlh.14363","DOIUrl":null,"url":null,"abstract":"IntroductionEpigenetics has been shown to be relevant in oncology: <jats:italic>BMI1</jats:italic> overexpression has been reported in leukemias, <jats:italic>EZH2</jats:italic> mutations have been found in follicular lymphoma, and <jats:italic>USP22</jats:italic> seems to stabilize BMI1 protein. In this study, we measured the expression of <jats:italic>BMI1, EZH2</jats:italic>, and <jats:italic>USP22</jats:italic> in lymph nodes from 56 diffuse large B‐cell lymphoma (DLBCL) patients.MethodsA new multiplex digital droplet PCR (ddPCR) has been set up to measure the expression of 4 genes (<jats:italic>BMI1, EZH2, USP22</jats:italic>, and <jats:italic>GAPDH</jats:italic>) in the same reaction on RNA extracted from paraffin‐embedded tissues.ResultsThe specificity of ddPCR was confirmed by a 100% alignment on the BLAST platform and its repeatability demonstrated by duplicates. A strict correlation between expression of <jats:italic>BMI1</jats:italic> and <jats:italic>EZH2</jats:italic> and <jats:italic>BMI1</jats:italic> and <jats:italic>USP22</jats:italic> has been found, and high expression of these genes was correlated with extra‐nodal lymphomas. Progression‐free survival (PFS) and overall survival (OS) were conditioned by IPI, bone marrow infiltration, and the complete response achievement. High levels of <jats:italic>BMI1</jats:italic> and <jats:italic>USP22</jats:italic> did not condition the response to therapy, but impaired the PFS, especially for patients defined at “high risk” based on the cell of origin (no germinal center [GCB]), high BCL2 expression, and IPI 3‐5. In this subgroup, the probability of relapse/progression was twice higher than that of patients carrying low <jats:italic>BMI1</jats:italic> and <jats:italic>USP22</jats:italic> levels.ConclusionHigh expression of <jats:italic>BMI1</jats:italic> and of <jats:italic>USP22</jats:italic> might be a poor prognostic factor in DLBCL, and might represent the target for novel inhibitors.","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes\",\"authors\":\"Alessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, Valter Gattei, Samantha Pozzi, Valentina Donati, Stefania Bettelli, Elisa Forti, Giovanna Mansueto, Arianna Di Napoli, Maria Christina Cox, Leonardo Flenghi, Pietro Rossi, Guido Volpe, Dimitri Dardanis, Clara Bono, Francesca Guerrini, Riccardo Morganti, Stefano Sacchi, Sara Galimberti\",\"doi\":\"10.1111/ijlh.14363\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"IntroductionEpigenetics has been shown to be relevant in oncology: <jats:italic>BMI1</jats:italic> overexpression has been reported in leukemias, <jats:italic>EZH2</jats:italic> mutations have been found in follicular lymphoma, and <jats:italic>USP22</jats:italic> seems to stabilize BMI1 protein. In this study, we measured the expression of <jats:italic>BMI1, EZH2</jats:italic>, and <jats:italic>USP22</jats:italic> in lymph nodes from 56 diffuse large B‐cell lymphoma (DLBCL) patients.MethodsA new multiplex digital droplet PCR (ddPCR) has been set up to measure the expression of 4 genes (<jats:italic>BMI1, EZH2, USP22</jats:italic>, and <jats:italic>GAPDH</jats:italic>) in the same reaction on RNA extracted from paraffin‐embedded tissues.ResultsThe specificity of ddPCR was confirmed by a 100% alignment on the BLAST platform and its repeatability demonstrated by duplicates. A strict correlation between expression of <jats:italic>BMI1</jats:italic> and <jats:italic>EZH2</jats:italic> and <jats:italic>BMI1</jats:italic> and <jats:italic>USP22</jats:italic> has been found, and high expression of these genes was correlated with extra‐nodal lymphomas. Progression‐free survival (PFS) and overall survival (OS) were conditioned by IPI, bone marrow infiltration, and the complete response achievement. High levels of <jats:italic>BMI1</jats:italic> and <jats:italic>USP22</jats:italic> did not condition the response to therapy, but impaired the PFS, especially for patients defined at “high risk” based on the cell of origin (no germinal center [GCB]), high BCL2 expression, and IPI 3‐5. In this subgroup, the probability of relapse/progression was twice higher than that of patients carrying low <jats:italic>BMI1</jats:italic> and <jats:italic>USP22</jats:italic> levels.ConclusionHigh expression of <jats:italic>BMI1</jats:italic> and of <jats:italic>USP22</jats:italic> might be a poor prognostic factor in DLBCL, and might represent the target for novel inhibitors.\",\"PeriodicalId\":14120,\"journal\":{\"name\":\"International Journal of Laboratory Hematology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Laboratory Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/ijlh.14363\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Laboratory Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ijlh.14363","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言表观遗传学已被证明与肿瘤学有关:据报道,BMI1在白血病中过表达,EZH2突变在滤泡性淋巴瘤中被发现,而USP22似乎能稳定BMI1蛋白。本研究测定了 56 例弥漫大 B 细胞淋巴瘤(DLBCL)患者淋巴结中 BMI1、EZH2 和 USP22 的表达。方法 建立了一种新的多重数字液滴 PCR(ddPCR),在同一反应中测量从石蜡包埋组织中提取的 RNA 中 4 个基因(BMI1、EZH2、USP22 和 GAPDH)的表达。结果发现,BMI1 和 EZH2 以及 BMI1 和 USP22 的表达之间存在严格的相关性,这些基因的高表达与结外淋巴瘤相关。无进展生存期(PFS)和总生存期(OS)受 IPI、骨髓浸润和完全反应成就的影响。高水平的BMI1和USP22不会影响治疗反应,但会影响无进展生存期,尤其是根据起源细胞(无生殖中心[GCB])、BCL2高表达和IPI 3-5定义的 "高危 "患者。结论BMI1和USP22的高表达可能是DLBCL的不良预后因素,可能是新型抑制剂的靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes
IntroductionEpigenetics has been shown to be relevant in oncology: BMI1 overexpression has been reported in leukemias, EZH2 mutations have been found in follicular lymphoma, and USP22 seems to stabilize BMI1 protein. In this study, we measured the expression of BMI1, EZH2, and USP22 in lymph nodes from 56 diffuse large B‐cell lymphoma (DLBCL) patients.MethodsA new multiplex digital droplet PCR (ddPCR) has been set up to measure the expression of 4 genes (BMI1, EZH2, USP22, and GAPDH) in the same reaction on RNA extracted from paraffin‐embedded tissues.ResultsThe specificity of ddPCR was confirmed by a 100% alignment on the BLAST platform and its repeatability demonstrated by duplicates. A strict correlation between expression of BMI1 and EZH2 and BMI1 and USP22 has been found, and high expression of these genes was correlated with extra‐nodal lymphomas. Progression‐free survival (PFS) and overall survival (OS) were conditioned by IPI, bone marrow infiltration, and the complete response achievement. High levels of BMI1 and USP22 did not condition the response to therapy, but impaired the PFS, especially for patients defined at “high risk” based on the cell of origin (no germinal center [GCB]), high BCL2 expression, and IPI 3‐5. In this subgroup, the probability of relapse/progression was twice higher than that of patients carrying low BMI1 and USP22 levels.ConclusionHigh expression of BMI1 and of USP22 might be a poor prognostic factor in DLBCL, and might represent the target for novel inhibitors.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.50
自引率
6.70%
发文量
211
审稿时长
6-12 weeks
期刊介绍: The International Journal of Laboratory Hematology provides a forum for the communication of new developments, research topics and the practice of laboratory haematology. The journal publishes invited reviews, full length original articles, and correspondence. The International Journal of Laboratory Hematology is the official journal of the International Society for Laboratory Hematology, which addresses the following sub-disciplines: cellular analysis, flow cytometry, haemostasis and thrombosis, molecular diagnostics, haematology informatics, haemoglobinopathies, point of care testing, standards and guidelines. The journal was launched in 2006 as the successor to Clinical and Laboratory Hematology, which was first published in 1979. An active and positive editorial policy ensures that work of a high scientific standard is reported, in order to bridge the gap between practical and academic aspects of laboratory haematology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信